Home > Financial Ratios > GLENMARK PHARMACEUTICALS

GLENMARK PHARMACEUTICALS
Fixed Capital/Sales

    Back to All Ratios
GLENMARK PHARMACEUTICALS is part of below Screeners ↓
Best Quarterly Growth Mid Cap Stocks
COMMUNITY POLL
for GLENMARK PHARMACEUTICALS
Please provide your vote to see the results

GLENMARK PHARMACEUTICALS Last 5 Year Fixed Capital/Sales History

[Consolidated]

Mar2025Mar2024Mar2023Mar2022Mar2021
   Fixed Capital/Sales(x) 0.340.360.360.340.34

What is the latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS ?

The latest Fixed Capital/Sales ratio of GLENMARK PHARMACEUTICALS is 0.34 based on Mar2025 Consolidated results.
Year Fixed Capital/Sales
Mar20250.34
Mar20240.36
Mar20230.36
Mar20220.34
Mar20210.34

How is Fixed Capital/Sales of GLENMARK PHARMACEUTICALS Trending?

Years Fixed Capital/Sales % Change
Mar2025 0.34
-5.56
Mar2024 0.36
0.00
Mar2023 0.36
5.88
Mar2022 0.34
0.00
Mar2021 0.34 -

Other Financial Ratios of GLENMARK PHARMACEUTICALS


Compare Fixed Capital/Sales ratio of peers of GLENMARK PHARMACEUTICALS

Peers & Returns Market Capitalization 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS ₹56,324.3 Cr -0.2% -2.1% 32.3% Stock Analytics
SUN PHARMACEUTICAL INDUSTRIES ₹392,147.0 Cr -2.1% -7.7% -9.7% Stock Analytics
DIVIS LABORATORIES ₹161,208.0 Cr -2.6% -6.8% 1.5% Stock Analytics
TORRENT PHARMACEUTICALS ₹136,190.0 Cr 0.1% 5.5% 25.3% Stock Analytics
CIPLA ₹110,790.0 Cr -1.9% -9.3% -5.1% Stock Analytics
DR REDDYS LABORATORIES ₹101,587.0 Cr 3.5% -5.2% -11.8% Stock Analytics


GLENMARK PHARMACEUTICALS Share Price vs Sensex


Share Price Returns(%) 1 Week 1 Month 1 Year
GLENMARK PHARMACEUTICALS

-0.2%

-2.1%

32.3%

SENSEX

-1.3%

-3.1%

6.8%


You may also like the below Video Courses